Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Pharmacokinetic–Pharmacodynamic Relationship: Problems

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Factors Affecting Drug Response: Overview

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Toxicology findings from drivers suspected of drug-impaired driving in Ontario (2008-2019).

Traffic injury prevention·2024

Same author

Enhancing the Standardized Field Sobriety Test to detect cannabis impairment: An observational study.

Traffic injury prevention·2023

Same author

Cannabis, alcohol and other drug findings in fatally injured drivers in Ontario.

Traffic injury prevention·2020

Same author

Predicting categories of drugs used by suspected drug-impaired drivers using the Drug Evaluation and Classification Program tests.

Traffic injury prevention·2019

Same author

Can progress in reducing alcohol-impaired driving fatalities be resumed? Results of a workshop sponsored by the Transportation Research Board, Alcohol, Other Drugs, and Transportation Committee (ANB50).

Traffic injury prevention·2016

Same author

The Standardized Field Sobriety Tests (SFST) and measures of cognitive functioning.

Accident; analysis and prevention·2015

Search research articles

Related Experiment Video

Updated: Jun 8, 2026

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

High-throughput Identification of Synergistic Drug Combinations by the Overlap² Method

Published on: May 21, 2018

Simplifying the process for identifying drug combinations by drug recognition experts.

Amy J Porath-Waller¹, Douglas J Beirness

¹Canadian Centre on Substance Abuse, Ottawa, Ontario, Canada. aporath-waller@ccsa.ca

Traffic Injury Prevention

|September 28, 2010

Summary

This study statistically identified key drug-related cues from Drug Evaluation and Classification (DEC) evaluations that predict drug categories in impaired drivers. These findings aid in training drug recognition experts (DREs) for safer roads.

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Related Experiment Videos

Last Updated: Jun 8, 2026

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

High-throughput Identification of Synergistic Drug Combinations by the Overlap² Method

Published on: May 21, 2018

Diagonal Method to Measure Synergy Among Any Number of Drugs

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Area of Science:

Forensic Science
Toxicology
Law Enforcement

Background:

Drug-impaired driving is a significant public safety concern.
Accurate identification of drug categories in suspected impaired drivers is crucial for effective law enforcement and judicial processes.
Current methods for drug recognition rely on expert interpretation of clinical signs.

Purpose of the Study:

To statistically identify drug-related cues from Drug Evaluation and Classification (DEC) evaluations that significantly predict drug categories in suspected impaired drivers.
To provide a data-driven foundation for improving drug recognition expert (DRE) training and decision-making.

Main Methods:

Analysis of 819 Canadian DEC evaluations involving combinations of CNS stimulants, cannabis, narcotic analgesics, alcohol, and no-drug cases.
Application of multinomial logistic regression to identify predictive clinical indicators.
Inclusion of data from various drug combinations and control (no-drug) cases.

Main Results:

Eleven clinical indicators from DEC evaluations significantly predicted drug categories.
Key indicators include eye condition, pupillary responses (convergence, light reaction, size in darkness), pulse rate, injection site evidence, and performance on field sobriety tests (Horizontal Gaze Nystagmus, One-Leg Stand, Walk-and-Turn).
Muscle tone was also identified as a significant predictor.

Conclusions:

The identified cues enhance the accuracy of classifying drugs used by suspected impaired drivers.
This research provides a statistically-based approach for DRE training, improving drug classification decisions.
Findings will support the enforcement of drug-impaired driving laws in Canada, contributing to road safety.